Collisions and Perceptions of Cyberbullying: Comparison of Intergenerational Experiences.

With regard to negative consequences, cyberbullying is recognized as one of the most traumatic types of cyber aggression. The aim is to study the specific features of adolescents and youth's cyberbullying experience in the role of an aggressor, victim or bystander, as well as awareness on the part of parents of adolescents. A total of 3395 adolescents, youth and parents filled out specially designed questionnaires.

Media Multitasking in Mixed Reality Learning Situations: What Determines Its Effectiveness?

Background: Media multitasking (MMT) is common among adolescents, especially with the introduction of digital educational tools in mixed reality environments. However, there has been limited research on MMT in educational settings with electronic learning tools including augmented reality (AR).

Objective: To study MMT in conjunction with metacognition, technology attitudes, and effectiveness of learning activities for 13-14 year olds in a mixed reality learning situation.

Multitasking as a Personal Choice of the Mode of Activity in Russian Children and Adolescents: Its Relationship to Experimental Multitasking and its Effectiveness.

Background: A person's ability to solve several tasks simultaneously, or within a limited amount of time, - , multitasking - is becoming more and more highly valued in society, despite experimental data in cognitive science about the low effectiveness of such activity. But, in the modern world, the term multitasking has become increasingly used in another sense - that is, a personal choice to perform several tasks simultaneously even if a person could do them consecutively.

Objective: The aim of this study was to reveal the relationship between a personal preference for multitasking, its subjective effectiveness in children and adolescents, and their tendency for and efficacy of multitasking under experimental conditions.

Human Gut Microbiome Response to Short-Term -Based Probiotic Treatment.

Gut microbiota is believed to play a crucial role in modulating obesity in humans, and probiotics affecting gut microbiota can alleviate some of the obesity-related health complications. The study was aimed to investigate changes in the composition of the gut microbiome in obese humans due to short-term (2 weeks) treatment of obese patients with a probiotic preparation containing . Faecal microbiome diversity was studied using the 16S amplicon sequencing by Illumina MiSeq.

Features of Media Multitasking in School-Age Children.

The paper addresses the phenomenon of media multitasking that is being widely spread among children and adolescents in the context of digital socialization. The previous research has revealed its strong connection with cognitive control, executive functions, and academic performance, yet the specificity and efficacy of media multitasking performance, especially among children while they carry out usual activities, remains insufficiently studied. A quasi-experimental study, including digital tasks of various types on a computer and smartphone, the dots task for executive functions, and a socio-psychological questionnaire, was conducted with the participants of three age groups: 7-10, 11-13, and 14-16 years old (N = 154).

Five-year disease-free survival among stage II-IV breast cancer patients receiving FAC and AC chemotherapy in phase II clinical trials of Panagen.

Background: We report on the results of a phase II clinical trial of Panagen (tablet form of fragmented human DNA preparation) in breast cancer patients (placebo group n = 23, Panagen n = 57). Panagen was administered as an adjuvant leukoprotective agent in FAC and AC chemotherapy regimens. Pre-clinical studies clearly indicate that Panagen acts by activating dendritic cells and induces the development of adaptive anticancer immune response.

Results of multicenter double-blind placebo-controlled phase II clinical trial of Panagen preparation to evaluate its leukostimulatory activity and formation of the adaptive immune response in patients with stage II-IV breast cancer.

Background: We performed a multicenter, double-blind, placebo-controlled, phase II clinical trial of human dsDNA-based preparation Panagen in a tablet form. In total, 80 female patients with stage II-IV breast cancer were recruited.

Methods: Patients received three consecutive FAC (5-fluorouracil, doxorubicin and cyclophosphamide) or AC (doxorubicin and cyclophosphamide) adjuvant chemotherapies (3 weeks per course) and 6 tablets of 5 mg Panagen or placebo daily (one tablet every 2-3 hours, 30 mg/day) for 18 days during each chemotherapy course.